Edesa Biotech, Inc.
Edesa Biotech, Inc. (EDSA) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · EDSA · as of Jun 8, 2026
Key Statistics
Explore Edesa Biotech, Inc. Data
edsa stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 2 · Buy rate: 100.0%
Competitors & Peers
edsa competitorsEDSA
BRTX
COCP
DWTX
ERNA
EVGNStock Performance
Full HistoryAbout Edesa Biotech, Inc.
Edesa Biotech, Inc. is a biopharmaceutical firm focused on discovering, developing, and commercializing clinical-stage treatments for inflammatory and immune system disorders where current medical opt…
what is edesa biotech, inc. · edsa stock overview · edesa biotech, inc. company profile · who is edesa biotech, inc. ceo · edsa NASDAQ · edesa biotech, inc. headquarters · edesa biotech, inc. business segments
About Stock Overview & Key Data
Edesa Biotech, Inc. (EDSA) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Jun 21, 2010. As of the latest trading session, EDSA stock price is $5.37, with a market capitalization of $47.7M. The stock has returned +173.98% over the past 12 months and +278.17% year-to-date.
According to 2 Wall Street analysts, the consensus rating for Edesa Biotech, Inc. stock is Buy, with an average 12-month price target of $—. In fiscal year 2025, Edesa Biotech, Inc. reported revenue of — and net income of -$7.2M. For detailed data — including Edesa Biotech, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Edesa Biotech, Inc. (EDSA) stock price is $5.37. The stock is traded on NASDAQ under the ticker symbol EDSA. The 52-week range is $0.72 – $20.32.